The decision to pursue cancer treatment abroad is one of the most significant a patient and their family can make. It is also one of the most misunderstood. International oncology care is not a last resort for patients who have run out of options at home. For a growing number of patients it is a deliberate, strategic first choice driven by access, cost, wait times, or the desire for an additional expert opinion from a world-class institution.
Understanding who seeks cancer treatment abroad and why helps patients evaluate whether international options make sense for their specific situation.
Uninsured and Underinsured US Patients
Cancer treatment in the United States is among the most expensive healthcare in the world. A single course of chemotherapy can cost $100,000 or more. Surgical oncology procedures run $50,000 to $200,000. For the estimated 25 million Americans who are uninsured or significantly underinsured, these figures make domestic treatment financially inaccessible. JCI-accredited international cancer centers in India, Thailand, and the UAE offer the same treatment protocols, the same drug regimens, and in many cases the same implant and prosthetic systems as leading US hospitals, at 60 to 80 percent lower cost.
Patients Seeking a Second Opinion
Second opinions save lives in oncology. Misdiagnosis rates in cancer are significant enough that major US medical institutions recommend second opinions routinely. For patients who have received a cancer diagnosis and want to have their pathology, imaging, and proposed treatment plan reviewed by a specialist team at an internationally accredited center, several MTA-verified hospitals in this guide offer formal international second opinion programs that can be accessed remotely or in person.
Patients Seeking Specific Treatments or Clinical Trials
Certain cancer treatments, immunotherapy protocols, and clinical trials are available at international centers before they reach standard care in a patient's home country, or at institutions with deeper specialist volume in specific cancer types. Patients with rare or complex cancers sometimes find that the institution with the greatest experience treating their specific diagnosis is not in their home country.
Patients Facing Long Wait Times
In countries with public healthcare systems, wait times for oncology consultations, diagnostic imaging, and treatment initiation can be weeks or months. For cancer patients for whom treatment speed is a clinical priority, private international care at an accredited hospital can begin within days.
Patients ready to connect with MTA-verified cancer centers can browse and submit a free inquiry at Better by MTA, the Medical Tourism Association's patient platform.
What Cancer Treatments Are Available Internationally
The range of oncology services available at internationally accredited hospitals covers the full spectrum of cancer care. Understanding what is available helps patients evaluate whether their specific treatment needs can be met abroad.
Surgical Oncology
Cancer removal surgery at JCI-accredited international hospitals is available for most solid tumor cancers including breast, colorectal, lung, prostate, gynecological, and hepatobiliary cancers. Minimally invasive and robotic-assisted surgery is available at the leading centers in this guide. Operative outcomes data at JCI-accredited hospitals is publicly comparable to leading US academic medical centers.
Medical Oncology and Chemotherapy
Chemotherapy, targeted therapy, and hormonal therapy using the same drug regimens as US and European oncology guidelines are available at all MTA-verified cancer centers in this guide. International centers follow NCCN guidelines or equivalent national protocols. Drug access for targeted therapies and immunotherapy agents is broadly comparable to US and European care at the leading hospitals covered here.
Radiation Oncology
Conventional radiation, IMRT (Intensity Modulated Radiation Therapy), SBRT (Stereotactic Body Radiation Therapy), and SRS (Stereotactic Radiosurgery) are available at several MTA-verified centers. Proton therapy, which delivers radiation with greater precision and less damage to surrounding tissue than conventional photon radiation, is available at select international centers, typically at significantly lower cost than the $30,000 to $120,000 charged for proton therapy in the United States.
Immunotherapy
Checkpoint inhibitor immunotherapy using PD-1 and PD-L1 inhibitors is available at all major centers in this guide for approved indications. CAR-T cell therapy, a more advanced cellular immunotherapy, is available at select institutions. Patients considering immunotherapy abroad should confirm specific drug availability for their cancer type and stage at the consultation stage.
Second Opinion Programs
Several MTA-verified hospitals offer formal international second opinion programs where a patient's pathology slides, imaging studies, genetic testing results, and proposed treatment plan are reviewed by a specialist multidisciplinary team. These programs can often be initiated remotely without the patient traveling, with the full written report provided within a specified timeframe. For patients who want an expert review of their diagnosis before committing to a treatment plan, this is the most accessible starting point.
How Much Does Cancer Treatment Cost Internationally
International cancer treatment costs vary significantly based on cancer type, stage, treatment modality, and length of treatment required. The following ranges provide realistic guidance for patients beginning their research.
Chemotherapy regimens run $3,000 to $30,000 per cycle internationally at the leading centers, compared to $10,000 to $100,000 per cycle in the United States for equivalent regimens. Over a full course of treatment involving multiple cycles, the aggregate savings can reach hundreds of thousands of dollars for complex cases.
Surgical oncology procedures at JCI-accredited international hospitals typically cost 60 to 80 percent less than equivalent procedures in the United States. A major cancer surgery costing $80,000 to $150,000 in the US commonly runs $15,000 to $40,000 at accredited international centers in India, Thailand, or the UAE.
Proton therapy, where available internationally, typically costs $20,000 to $50,000 compared to $30,000 to $120,000 in the United States.
Second opinion programs at international centers typically run $500 to $3,000 for a comprehensive multidisciplinary review, making them accessible as a standalone service even for patients who ultimately pursue treatment domestically.
Cost estimates are industry averages and vary by cancer type, stage, treatment protocol, hospital, and length of stay. Always request a fully itemized treatment plan and cost estimate based on your specific diagnosis and proposed protocol before making any decisions.
MTA Verified Cancer Treatment Centers
Apollo Hospitals Enterprise — MTA Verified
Apollo Hospitals is India's largest private healthcare network and one of the most studied hospital systems in Asia for international oncology outcomes. The group's flagship Chennai campus, where Apollo's international patient center is based, offers a comprehensive cancer program covering surgical oncology, medical oncology, radiation, nuclear medicine, bone marrow transplantation, and a dedicated international second opinion service.
India's cost advantage for cancer treatment is among the largest of any medical tourism destination globally. Treatment that costs $100,000 to $300,000 in the United States is available at Apollo at $15,000 to $50,000 for comparable protocols. For uninsured US patients and for international patients from lower-income countries, Apollo's combination of JCI-accredited standards and dramatically lower costs represents a genuinely life-changing access point.
The hospital's international patient center manages patients from arrival through discharge, with dedicated case managers, translation, visa support, and accommodation coordination. Over 140 nationalities have been treated at Apollo hospitals.
Location: Greams Lane, 21, Greams Rd, Thousand Lights West, Chennai, Tamil Nadu 600006, IndiaSpecialties: Surgical Oncology, Medical Oncology, Radiation Oncology, Bone Marrow Transplant, Nuclear Medicine, Second Opinion ProgramAccreditation: JCI AccreditedLanguages: English, Tamil, Hindi, and additional via translation
View Apollo Hospitals on Better by MTA
Bumrungrad International Hospital — MTA Verified
Bumrungrad International in Bangkok is consistently ranked among the most studied and most trusted international hospitals in the world for oncology. The hospital treats patients from over 190 countries annually and its oncology program covers the full spectrum of cancer treatment within a fully integrated multi-specialty hospital that is one of Asia's most comprehensive private medical institutions.
Thailand's position as a medical tourism destination gives Bumrungrad a specific advantage for Western patients seeking cancer care in Asia: the hospital's physical environment, international patient services, English-language care, and cultural familiarity are among the highest quality of any hospital in the region. Patients who might find the logistics of other Asian destinations more challenging typically describe Bumrungrad's patient experience as comparable to a premier US private hospital at a fraction of the cost.
Location: 33 Soi Sukhumvit 3, Sukhumvit Road, Khlong Toei Nua, Watthana, Bangkok 10110, ThailandSpecialties: Surgical Oncology, Medical Oncology, Radiation Oncology, Minimally Invasive Cancer Surgery, Cancer ScreeningAccreditation: JCI AccreditedLanguages: English, Thai, Arabic, Japanese, and additional via international team
View Bumrungrad International Hospital on Better by MTA
Humanitas Research Hospital — MTA Verified
Humanitas Research Hospital near Milan is one of Europe's most respected oncology institutions and one of the few international hospitals that combines clinical cancer care at the highest European standards with an active research and clinical trials program. The hospital is affiliated with the University of Milan and publishes extensively in international oncology literature, giving patients access to treatments within active research protocols not yet in standard care.
For European patients, North American patients who want European-standard care at lower cost than domestic private treatment, and patients with specific cancer types where Humanitas has published research depth, the combination of clinical excellence, research access, and Italy's established international patient infrastructure makes Humanitas a compelling option.
Location: Via Alessandro Manzoni 56, 20089 Rozzano, Milan, ItalySpecialties: Surgical Oncology, Medical Oncology, Radiation Oncology, Robotic Surgery, Clinical Trials, Research OncologyAccreditation: JCI Accredited, University of Milan affiliatedLanguages: English, Italian, and additional via international team
View Humanitas Research Hospital on Better by MTA
King Faisal Specialist Hospital and Research Centre — MTA Verified
King Faisal Specialist Hospital and Research Centre in Riyadh is Saudi Arabia's foremost oncology institution and one of the most respected cancer centers in the Middle East and North Africa region. The hospital's research center designation reflects a genuine commitment to clinical investigation alongside patient care, with active clinical trials programs and specialist depth in cancer types prevalent in the MENA region.
For patients from across the Middle East, South Asia, and North Africa, King Faisal represents the highest level of oncology care available within the region, with international patient coordination services and a research pedigree that places it alongside the leading academic cancer centers globally.
Location: Riyadh, Saudi ArabiaSpecialties: Full spectrum oncology, Bone Marrow Transplant, Pediatric Oncology, Research Oncology, Clinical TrialsAccreditation: JCI AccreditedLanguages: Arabic, English
View King Faisal Specialist Hospital on Better by MTA
King's College Hospital Dubai — MTA Verified
King's College Hospital Dubai brings the brand and clinical standards of one of the United Kingdom's most respected teaching hospitals to the UAE, operating as a fully equipped multi-specialty hospital with a dedicated oncology program. For patients from the UK who want access to King's clinical standards in a Dubai setting, for Middle Eastern patients seeking Western-affiliated cancer care, and for international patients who want European-standard oncology in the most internationally connected city in the region, King's College Hospital Dubai fills a specific and important position.
Location: Dubai Hills, Dubai, United Arab EmiratesSpecialties: Medical Oncology, Surgical Oncology, Cancer Diagnostics, Second Opinion ProgramAffiliation: King's College Hospital LondonLanguages: English, Arabic, and additional via international team
View King's College Hospital Dubai on Better by MTA
Burjeel Medical City — MTA Verified
Burjeel Medical City in Abu Dhabi is one of the UAE's most comprehensive private medical institutions, with a dedicated cancer center offering surgical, medical, and radiation oncology within a purpose-built multi-specialty hospital. The center serves the Abu Dhabi catchment area and a significant international patient base from South Asia, Africa, and Europe, with a specific focus on delivering Western-standard oncology care with the accessibility and cost structure of a Gulf healthcare market.
Location: Mohamed Bin Zayed City, Abu Dhabi, UAESpecialties: Surgical Oncology, Medical Oncology, Radiation Oncology, Nuclear Medicine, Bone Marrow TransplantAccreditation: JCI AccreditedLanguages: English, Arabic, Hindi, and additional via international team
View Burjeel Medical City on Better by MTA
How to Access a Second Opinion at an International Cancer Center
For many patients, a second opinion from an internationally accredited cancer center is the most appropriate first step, and it is more accessible than most patients realize.
Most of the MTA-verified cancer centers in this guide offer formal second opinion programs that can be initiated remotely. The process typically involves submitting a medical summary package that includes pathology reports and slides, radiology imaging with reports, current staging documentation, previous treatment history if applicable, and any genetic testing results.
The hospital's specialist oncology team reviews the full package, and a written report is returned to the patient typically within one to two weeks. The report may confirm the proposed diagnosis and treatment plan, suggest modifications, recommend additional testing, or identify alternative treatment approaches. For patients facing a major treatment decision, the cost of a formal second opinion is minimal compared to its potential value.
Patients who want to travel to the cancer center for an in-person second opinion consultation can typically schedule this within a short timeframe at any of the hospitals in this guide. The centers all have international patient coordinators who manage the logistics of this process for visiting patients.
What to Ask Before Committing to Cancer Treatment Abroad
Cancer treatment decisions are among the most consequential anyone makes. These questions should be clearly answered before any patient commits to treatment at an international center.
- Is the hospital JCI accredited, and can you verify the accreditation directly through the JCI public database at jointcommissioninternational.org
- What specific drug regimens and treatment protocols are used, and how do they compare to the standard of care in your home country
- Who is the specific oncologist who will manage your care, and what is their training background, specialty certification, and case volume in your cancer type
- How will the hospital coordinate with your home oncologist during and after treatment, and what documentation will be provided
- What is the process if you experience complications or side effects after returning home
- Is your proposed treatment available at this hospital specifically, rather than just at the institution generally
- What is the fully itemized treatment cost estimate based on your specific diagnosis, stage, and proposed protocol
Never make a cancer treatment decision based on cost alone. The financial considerations are real and legitimate, particularly for uninsured patients. But clinical factors must be evaluated alongside cost, and the hospital's specific experience with your cancer type is among the most important variables.
Use an MTA Verified provider for all international cancer care considerations. Every hospital in this guide has been reviewed by the Medical Tourism Association. Connect with them through Better by MTA.
An Important Note on Medical Advice
Better by MTA and the Medical Tourism Association do not provide medical advice. Nothing in this guide constitutes a recommendation for any specific treatment, treatment center, or course of action for any individual patient. All cancer treatment decisions should be made in consultation with your current oncologist and any additional specialists whose opinion you seek. The information in this guide is for educational purposes to help patients understand what international cancer care involves and which MTA-verified providers serve international oncology patients.
Ready to Connect With an International Cancer Center
Better by MTA connects you with MTA-verified oncology hospitals worldwide. One free inquiry, no obligation, no intermediary fees.
Get My Free Cancer Care Inquiry Started
Browse All Verified Oncology Providers on Better by MTA
By Jonathan Edelheit, CEO and Co-Founder, Medical Tourism Association. Last updated May 2026.
.png)
